T0	Participants 69 101	advanced, life-limiting illness:
T1	Participants 147 178	patients with limited prognosis
T2	Participants 389 427	patients with limited life expectancy.
T3	Participants 528 568	patients in the palliative care setting.
T4	Participants 680 959	Eligibility included adults with an estimated life expectancy of between 1 month and 1 year, statin therapy for 3 months or more for primary or secondary prevention of cardiovascular disease, recent deterioration in functional status, and no recent active cardiovascular disease.
T5	Participants 1097 1141	conducted from June 3, 2011, to May 2, 2013.
T6	Participants 1616 1654	A total of 381 patients were enrolled;
T7	Participants 1753 1864	Mean (SD) age was 74.1 (11.6) years, 22.0% of the participants were cognitively impaired, and 48.8% had cancer.